Part of Phaidon International
Part of Phaidon International
Showing 6 results
Sort by:
Role: VP of Quality Location: Boston, MA (On-site)Salary: $250k-$350kEPM Scientific is partnering with a rapidly growing structural heart medical device company that is advancing innovative therapies for patients with complex cardiovascular conditions. Following significant clinical progress, strong investor backing, and continued organizational gr...
Oncology Account ManagerTerritory: MA, NH, RI, ME, and parts of Upstate NYCompany: Midsized Pharmaceutical Company Role OverviewA midsized pharmaceutical company is seeking a dedicated Oncology Account Manager to cover their Boston territory. This role is pivotal in driving sales and establishing strong relationships with key thought leaders and pr...
Role: Senior IT Business Analyst, GxP SystemsLocation: Boston, MASalary: $115k - $170k EPM is partnered with a clinical-stage biotechnology company developing next-generation genetic medicines for serious diseases. Leveraging a proprietary RNA-based platform, the organization is advancing multiple clinical and preclinical programs while continuing ...
Take the first step toward your next opportunity - submit your CV and get started today.
Sr. Principal Scientist, Cell Line DevelopmentSummaryOur firm is currently partnered with a growing biopharmaceutical development organization seeking an Associate Director of Cell Line Development to lead its mammalian cell line and microbial strain development capabilities.This individual will lead a team of scientists and associates responsible ...
Vice President / Senior Vice President Global Regulatory Affairs (Oncology)A clinical‑stage biotechnology company pioneering next‑generation precision oncology therapeutics is seeking a Vice President/Senior Vice President Global Regulatory Affairs. Their approach is integrating cutting‑edge translational science, advanced patient‑selection methodo...
Role: Research EngineerLocation: Boston, MAEPM is partnered with an innovative structural heart company developing next-generation catheter-based technologies designed to repair and modify native heart valve tissue through minimally invasive procedures. With an FDA-cleared commercial product, an expanding clinical-stage pipeline targeting both aor...